TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
PALI

Palisade Bio Inc

Healthcare · Biotechnology

1.50$ +3.4% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

Palisade Bio Inc (PALI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -11 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow PALI
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-12 -19 -16 -13 -7.7 -7.3 -4.8 -15 -13 -11 -12 -11
0.3 0.3 0.3 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0
4.3 3.0 3.4 1.8 1.1 3.3 2.0 1.9 1.0 0.6 0.7 4.0
– – – – 1.3 2.8 3.0 14 – – – –
12 -2.2 1.5 -2.2 -0.3 0.2 2.4 -4.8 1.3 0.4 1.4 1.6
0.6 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
-16 7.2 2.4 -0.1 5.0 3.9 0.0 -0.1 0.0 0.0 – –
– – – – – – – 0.1 – – – –
– – 28 8.7 1.8 6.6 15 -0.1 – 0.0 0.0 0.0
– – – – 1.4 -0.2 2.0 -0.2 -0.8 -0.4 -0.4 -0.3
23 3.9 24 5.0 1.8 6.6 1.9 25 15 11 9.6 134
-4.3 -7.8 10 -8.5 -0.9 -0.7 -2.9 9.8 1.9 0.0 -2.6 124
-12 -19 -16 -14 -7.7 -7.3 -4.8 -15 -13 -11 -12 -11

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?